(Q36661752)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123267%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

review article

1 reference

title

The prognostic significance of perineural invasion in prostatic cancer biopsies: a systematic review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123267%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123267%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Patricia Harnden

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123267%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Michael D Shelley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123267%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Hayley Clements

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123267%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

R Sandy Tyndale-Biscoe

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123267%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Brian Naylor

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123267%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Malcolm D Mason

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123267%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

language of work or name

English

0 references

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123267%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

number of pages

12

1 reference

inferred from page(s)

published in

Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123267%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123267%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123267%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

13-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17123267%20AND%20SRC:MED&resulttype=core&format=json

Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.

22 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Estimating the risk of long-term erectile, urinary and bowel symptoms resulting from prostate cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Aggressive basal cell carcinoma: presentation, pathogenesis, and management

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

The role of perineural space invasion in the local spread of prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Neuroanatomy of the normal prostate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Growth and survival mechanisms associated with perineural invasion in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Biochemical failure rates in prostate cancer patients predicted to have biologically insignificant tumors treated with three-dimensional conformal radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Interphase cytogenetic study of preoperative core biopsies for the prediction of early serum prostate specific antigen recurrence after radical prostatectomy of clinically localized prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Preoperative parameters for predicting early prostate cancer recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Contemporary preoperative parameters predict cancer-free survival after radical prostatectomy: a tool to facilitate treatment decisions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Influence of biopsy perineural invasion on long-term biochemical disease-free survival after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Perineural invasion and MIB-1 positivity in addition to Gleason score are significant preoperative predictors of progression after radical retropubic prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Is there a subset of patients with PSA > or = 20 ng/ml who do well after conformal beam radiotherapy?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Perineural invasion and Gleason 7-10 tumors predict increased failure in prostate cancer patients with pretreatment PSA <10 ng/ml treated with conformal external beam radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Perineural invasion is associated with increased relapse after external beam radiotherapy for men with low-risk prostate cancer and may be a marker for occult, high-grade cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Evidence of increased failure in the treatment of prostate carcinoma patients who have perineural invasion treated with three-dimensional conformal radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Pathologic features from prostate needle biopsy and prognosis after I-125 brachytherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Relationship between prostate volume, prostate-specific antigen nadir, and biochemical control

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Percentage of positive biopsy cores as predictor of clinical outcome in prostate cancer treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Prognostic significance of perineural invasion on biochemical progression-free survival after prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Prostate cancer radiotherapy dose response: an update of the fox chase experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Reporting recommendations for tumor marker prognostic studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

The process for continuous improvement of the TNM classification

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Multiple measures of carcinoma extent versus perineural invasion in prostate needle biopsy tissue in prediction of pathologic stage in a screening population

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Experiments to determine whether recursive partitioning (CART) or an artificial neural network overcomes theoretical limitations of Cox proportional hazards regression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021

Identification of clinically useful cancer prognostic factors: what are we missing?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22388

7 January 2021